Description:
Huifeng Bio-Pharmaceutical Technology, Inc. (HFGB), through its subsidiaries, is principally engaged in the manufacture of plant extracts and biochemical products in the People’s Republic of China, for sale in the People’s Republic of China market, Japan and some European countries. HFGB, through its wholly owned subsidiary, Northwest BioTechnic Inc. (NBTI), owns 100% of Huifeng Biochemistry Joint Stock Company (Huifeng), which produces and sells plant extracts, biochemical products and pharmaceutical raw products in the People’s Republic of China. Huifeng possesses advanced Rutin-refining technologies and is a Rutin supplier for the world market. On June 28, 2009, the Company’s subsidiary, Xi’an Huifeng Bio-Technic Inc., disposed its 70% interest in Xi’an Huifeng Biochemistry Engineering Company Limited, located in Fenghui, Changan, Xian.
Officers and Directors:
| Jing'an Wang |
|
Chairman of the Board, Chief Executive Officer |
|
|
Age: 49
|
| Sanding Tao |
|
Chief Financial Officer |
|
|
Age: 41
|
| Xiaoli Sun |
|
Independent Director |
|
|
Age: 52
|
| John Jing Zhang |
|
Independent Director |
|
|
Age: 39
|
| Chi Keung Lui |
|
Independent Director |
|
Click here to view stock quote
Contact:
16B/F Ruixin Road Bldg. No. 25 Gaoxin Road
Xi An, SHX 710075
China
+86-29-88246358 (Phone)
|
